Navigation Links
Mirixa Names New VP of Sales and Business Development
Date:12/13/2011

RESTON, Va., Dec. 13 , 2011 /PRNewswire/ -- Mirixa Corporation, the leader in pharmacy-based patient care services, is pleased to announce that Stacey Lelko has joined the company as Vice President of Sales and Business Development.  Ms. Lelko will lead Mirixa's national sales team and develop strategic partner relationships. 

(Logo:  http://photos.prnewswire.com/prnh/20100818/SF51721LOGO)

Ms. Lelko most recently served as Vice President of Strategic Partnerships for the Center for Health Transformation (CHT), an organization that brings together public and private leaders to effect positive change in the healthcare sector.  Prior to her work at CHT, Ms. Lelko held senior positions with pharmaceutical companies Eli Lilly and Schering Plough, and has extensive experience partnering with health plans and integrated delivery networks.  

"Stacey's depth of experience  managing successful sales organizations and forming teams for new markets will help us grow our leadership position," said Rick Solano, CEO of Mirixa.  "Our marketplace is expanding as new models of care delivery are being developed, and Stacey's skills and experience are right in line with what we need to  lead in this changing landscape."

Ms. Lelko will be based in the company's Reston, VA headquarters.

About Mirixa
Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network.  Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services.  For more information, please visit

SOURCE Mirixa Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mirixa to Support CDPHP®s MTM Service Delivery
2. Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform
3. MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC
4. Kerr Drug to Deploy Mirixa Technology for Clinical Services
5. Mirixa Australia Achieves Six Month Milestones
6. Mirixa Corporation Announces MirixaEdge(SM)
7. Mirixa Corporation Announces Key Pharmacy Network Hire
8. Ametros Financial Names Thomas Ash as CEO
9. Mylan Names John Thievon President of Dey Pharma
10. Forbes Names SynCardia One of "Americas Most Promising Companies"
11. ThermalTherapeutic Systems, Inc. Names Gardiner F. H. Smith, President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Israel, Aug. 31, 2015  Chiasma, Inc. (NASDAQ: ... developing octreotide capsules for the orphan condition acromegaly, ... ended June 30, 2015 and provided a corporate ... been a transformative time for Chiasma, as we ... announced that our first New Drug Application (NDA) ...
(Date:8/31/2015)... , August 31, 2015 ... that the global cardiovascular monitoring and diagnostic devices ... is predicted to reach a value of approximately ... of 9.7% between 2013 and 2019. The title ... Devices Market (ECG, Holter Monitors, Event Monitors, Cardiovascular ...
(Date:8/31/2015)... NEW YORK , Aug. 31, 2015  Dipexium ... company focused on the development and commercialization of Locilex® ... peptide, today announced plans to participate in four investor ... September 2, 2015 at the Sidoti & Company, LLC ... City . David P. Luci , President ...
Breaking Medicine Technology:Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3
... YORK, July 8, 2011 The U.S. Food and ... Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for ... for active booster immunization against tetanus, diphtheria and pertussis ... vaccine approved for use in this age group.  With ...
... July 8, 2011 /PRNewswire-Asia/ -- Shenzhen Wuzhou Changlian International ... of multifunctional medical and industrial products, is pleased to ... Up to a 35% discount will be offered in ... promotional activity range from infrared thermometers , digital ...
Cached Medicine Technology:GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 2GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 3GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older 4Enjoy Only One Thermometer in Various Domains 2
(Date:9/1/2015)... ... September 01, 2015 , ... ... Nurse Scholar-in Residence at the Institute of Medicine (IOM) of the National Academies. ... at Columbia University School of Nursing. A member of the Institute of Medicine ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... 1,500 investor-families have received permanent green cards (I-829 petition approval) from the USCIS ... petition is the final step of the EB-5 visa process for immigrant investors ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... 9, 2015 from 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 ... with career opportunities will be attending from across the country. All specialties will ...
(Date:9/1/2015)... ... September 01, 2015 , ... Situations ... seldom arise at the most convenient time for everyone involved. These occasions highlight ... , Universal Translation Services has real people available to handle any ...
(Date:9/1/2015)... Las Vegas, NV (PRWEB) , ... September 01, ... ... home care or Self-Directed Care is, how to access caregivers and what to ... of other valuable and pertinent information. , Founded in 2006 in Canoga Park, ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2
... Echo Therapeutics,Inc. (OTC Bulletin Board: ECTE), a ... had completed an approximately,$2.3 million private financing with ... and certain other select institutional and strategic,investors of ... $2,292,459 in aggregate principal amount of Senior Convertible,Notes ...
... Ehmke,Manufacturing Company of Philadelphia was among the ... 23 industry partners, customers and,individuals Feb. 12 ... received the Innovative Business Performer of the ... zone, small business,category. The award recognizes large, ...
... Corporation,(Nasdaq: VOLC ), a leading provider of intravascular ... the diagnosis and,treatment of coronary and peripheral vascular disease, ... 2007., For the quarter ended December 31, 2007, ... the company, and a 35 percent increase,over revenues of ...
... PT ... -, SAN JOSE, ... Board: PDXC), a provider of,veterinary primary care and specialized services to companion animals,today ... 20th Annual OC Growth Stock Conference on Wednesday,February 20 at 8:30 a.m. Pacific ...
... Breast Cancer Survivors , Breast cancer survivors, ... death from non-cancer causes than from breast cancer. ... are surviving longer, and many are dying of ... and colleagues with the National Cancer Institute of ...
... spread, researchers say , , TUESDAY, Feb. 12 (HealthDay News) -- ... ductal carcinoma in situ (DCIS) are highly anxious about their ... recurrence or of developing invasive breast cancer, a new study ... they,re waiting for the other shoe to drop," said lead ...
Cached Medicine News:Health News:Echo Therapeutics Announces Closing of Approximately $2.3 Million Private Financing 2Health News:Echo Therapeutics Announces Closing of Approximately $2.3 Million Private Financing 3Health News:Defense Logistics Agency Recognizes Ehmke Manufacturing Company 2Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 2Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 3Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 4Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 5Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 6Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 7Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 8Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 9Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 10Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 11Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 12Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 13Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 14Health News:Volcano Reports 35 Percent Increase in Quarterly Revenues; IVUS Disposable Revenues Increase 46 Percent 15Health News:Pet DRx to Present at Roth 20th Annual OC Growth Stock Conference 2Health News:Other highlights in the Feb. 12 JNCI 2Health News:Other highlights in the Feb. 12 JNCI 3Health News:Other highlights in the Feb. 12 JNCI 4Health News:Precancerous Breast Lesions Cause Unnecessary Worry 2Health News:Precancerous Breast Lesions Cause Unnecessary Worry 3Health News:Precancerous Breast Lesions Cause Unnecessary Worry 4
Inquire...
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: